I want to add the following. I'm an IT professional. In the course of my professional duties, I'm expected to…
Morning Headlines 5/8/18
Paul Singer’s Elliott makes all-cash offer for Athenahealth of $160 a share
Elliott Management makes an all-cash offer of $160 per share for Athenahealth, putting the transaction’s total value at more than $6 billion.
MTBC Signs Acquisition Agreement that could Increase Revenues by at least 50%
MTBC will acquire the practice management, revenue cycle, and group purchasing organization assets of Houston-based Orion Healthcorp and its 13 affiliates.
How to Lose $700 Million, Theranos-Style
Wall Street Journal Theranos investigator John Carreyrou uncovers a list of high-profile investors who helped Theranos secure over $700 million in funding.
athena will be out of the hospital space and focus exclusively on their core ambulatory when this merger happens. Total available market for hospital is shrinking with market pressure from new and increased entrants to the small hospital space. There is no path to profitability in that race to the bottom. Look for them to try and reinvent as an app maker.
the real play is in monetizing the data. i’d wager it’s worth more than the rest of the company.
Is this the Cambridge Analytics model?
It amazes me how much blame Facebook has successfully deflected onto Cambridge Analytica.
Athenahealth has always struggled with monetizing the data because they don’t own the data. They own the right to use de-identified aggregate data (which they use in things their flu trend reporting); but most of the valuable applications of data in healthcare require PHI that is either not de-identified or is easily re-identified, which Athena doesn’t have the right to sell. So much as they would like to monetize the data, it’s always been out of their reach.